As President & COO of Bench International and Co-Founder of the Bench International Technology Team (BITT), Chris advises clients at the intersection of life sciences, patient healthcare, and technology, helping organizations secure leaders fluent in digital innovation, data-driven decision making, and platform integration.
Chris’ career in biotechnology has spanned 40 years, including 16 years with biotechnology pioneer Amgen where he held roles in research, human resources, product licensing, and corporate development. During his tenure in human resources, Chris led the company’s recruitment activities during some of its most dramatic periods of growth as it evolved from a biotechnology R&D organization into a fully integrated pharmaceutical company. His recruitment responsibilities spanned research, clinical development, manufacturing, and commercialization.
As a business development executive with Amgen, Chris played a leadership role in evaluating and negotiating corporate collaborations and partnerships, with a particular focus on product and technology opportunities that advanced patient healthcare. This work built a foundation for his ongoing expertise in aligning life sciences with technology to drive innovation.
Following Amgen and prior to joining Bench, Chris held executive management positions with two privately held biotechnology companies, where he played a leadership role in business development and financing activities.
Chris holds a B.S. in microbiology from the University of Oklahoma and an M.S. from the University of California, Riverside.